Riskpilot← Back to searchSign inGet full accessJRS-AS
ASActiveOrg 997759095Oddenveien 19A, 1363 HøvikGeneral medical practice activities · NACE 8621Est. 20110 employees
Revenue 2024
NOK 0
EBITDA margin
—
+21% vs 2023
Equity ratio
1.1%
Financial strength
Net profit 2024
NOK 5,2M
+66137% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -6K | +21% |
| Net profit | NOK 5,2M | +66137% |
| Total assets | NOK 5,6M | +1974% |
| Equity | NOK 62K | -77% |
| Employees | 0 | — |
Legal name
JRS-AS
Org number
997759095
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
22. desember 2011
Share capital
NOK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Formålet er legevirksomhet, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag. Konsulentvirksomhet foruten forvaltning av selskapets kapital og ressurser i form av investeringer i eiendom, verdipapirer og andre finansielle instrumenter.
Address
Oddenveien 19A, 1363 Høvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 204 | 304 | 472 | 583 | 289 | 145 | 0 | 24 | 0 | 19 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −1 | −6 | −1 | −1 | −5 | −7 | −8 | −8 | −6 | −0 | −0 | −0 | −0 |
| EBITDA | 134 | 191 | 319 | 379 | 113 | −32 | −103 | −95 | −101 | −44 | −12 | −10 | −8 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −47 | −51 | −51 | −51 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 134 | 191 | 319 | 379 | 113 | −79 | −155 | −146 | −152 | −44 | −12 | −10 | −8 | −6 |
| Net financials | 0 | 0 | 0 | 6 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 5 220 |
| Profit before tax | 134 | 191 | 320 | 385 | 117 | −78 | −154 | −146 | −152 | −44 | −12 | −10 | −8 | 5 214 |
| Tax | 35 | 54 | 90 | 104 | 32 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 99 | 137 | 230 | 281 | 85 | −78 | −154 | −146 | −152 | −44 | −12 | −10 | −8 | 5 214 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 230 | 419 | 751 | 1 130 | 1 235 | 1 189 | 691 | 611 | 384 | 303 | 286 | 278 | 270 | 5 598 |
| Equity | 208 | 345 | 575 | 786 | 871 | 793 | 639 | 493 | 341 | 297 | 285 | 275 | 267 | 62 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 803 |
| Short-term debt | 22 | 74 | 177 | 345 | 364 | 396 | 52 | 118 | 43 | 6 | 1 | 3 | 3 | 4 733 |
| Total debt | 22 | 74 | 177 | 345 | 364 | 396 | 52 | 118 | 43 | 6 | 1 | 3 | 3 | 5 536 |
EBITDA margin
-632300.0%
This company
15.8%
Market median
-4001999% vs market
20112024
Equity ratio
1.1%
This company
38.2%
Market median
-97% vs market
20112024
Return on equity
8443.1%
This company
18.4%
Market median
+45786% vs market
20112024
Net profit margin
521362000.0%
This company
8.1%
Market median
+6436567801% vs market
20112024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20112024
Debt / equity
89.65×
This company
0.62×
Market median
-14360% vs market
20112024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-11-16 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
SF Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JRS-AS 
OSLO UROLOGISKE KLINIKK ASBoard members of JRS-AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon-Roar Hoff | Chief Executive Officer | 0 companies |
| Siri Foss | Chief Executive Officer | 0 companies |